IMUC — Eom Pharmaceutical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $20.39m
- $22.23m
Annual cashflow statement for Eom Pharmaceutical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2015 December 31st | 2016 December 31st | 2017 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.8 | -22.1 | -14.3 | -1.45 | -5.15 |
| Depreciation | |||||
| Non-Cash Items | -1.92 | -2.08 | -4.88 | 0.079 | 2.51 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.36 | 4.23 | 2.47 | 0.137 | 0.333 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -19 | -19.9 | -16.7 | -1.24 | -2.31 |
| Capital Expenditures | -0.17 | -0.004 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | 0.001 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.17 | -0.004 | 0.001 | — | — |
| Financing Cash Flow Items | 3.98 | 1.46 | 0 | 0 | 1.03 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 18.6 | 8.7 | 11.9 | 1.5 | 3.53 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.618 | -11.2 | -4.81 | 0.263 | 1.22 |